Clinical application of a novel sliver nanoparticles biosensor based on localized surface plasmon resonance for detecting the microalbuminuria

Acta Biochimica et Biophysica Sinica

Volumn 42, Issue 11, 2010, Pages 787-792

  Lai, Ting ^a   Hou, Qiannan ^a   Yang, Huan ^b   Luo, Xiangang ^b   Xi, Mingrong ^a  

^a SICHUAN UNIVERSITY   (China)

^b INSTITUTE OF OPTICS AND ELECTRONICS   (China)

Author keywords

biosensor; localized surface plasmon resonance (LSPR); microalbuminuria

Indexed keywords

IMMOBILIZED ANTIBODY; METAL NANOPARTICLE; SERUM ALBUMIN; SILVER;

ALBUMINURIA; ARTICLE; CHEMISTRY; FEMALE; GENETIC PROCEDURES; HUMAN; IMMUNOLOGY; METHODOLOGY; PREECLAMPSIA; PREGNANCY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SURFACE PLASMON RESONANCE; URINE;

ALBUMINURIA; ANTIBODIES, IMMOBILIZED; BIOSENSING TECHNIQUES; FEMALE; HUMANS; METAL NANOPARTICLES; PRE-ECLAMPSIA; PREGNANCY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN; SILVER; SURFACE PLASMON RESONANCE;

EID: 78049482365     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmq085     Document Type: Article

References (26)

1. Anker JN, Hall WP, Lyandres O, Shah NC, Zhao J and Van Duyne RP. Biosensing with plasmonic nanosensors. Nat Mater 2008, 7:442-453.
2. Nam JM, Thaxton CS and Mirkin CA. Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science 2003, 301:1884-1886.
3. Chen Y, Munechika K and Ginger DS. Dependence of fluorescence intensity on the spectral overlap between fluorophores and plasmon resonant single silver nanoparticles. Nano Lett 2007, 7:690-696.
4. Haes AJ, Chang L, Klein WL and Van Duyne RP. Detection of a biomarker for Alzheimer's disease from synthetic and clinical samples using a nanoscale optical biosensor. J Am Chem Soc 2005, 127:2264-2271.
5. Nath N and Chilkoti A. Label-free biosensing by surface plasmon resonance of nanoparticles on glass: optimization of nanoparticle size. Anal Chem 2004, 76:5370-5378.
6. Nath N and Chilkoti A. A colorimetric gold nanoparticle sensor to interrogate biomolecular interactions in real time on a surface. Anal Chem 2002, 74:504-509.
7. Fujiwara K, Watarai H, Itoh H, Nakahama E and Ogawa N. Measurement of antibody binding to protein immobilized on gold nanoparticles by localized surface plasmon spectroscopy. Anal Bioanal Chem 2006, 38:639-644.
8. Endo T, Yamamura S, Kerman K and Tamiya E. Label-free cell-based assay using localized surface plasmon resonance biosensor. Anal Chim Acta 2008, 614:182-189.
9. Haes AJ, Hall WP, Chang L, Klein WL and Van Duyne RP. A localized surface plasmon resonance biosensor: first steps toward an assay for Alzheimer's disease. Nano Lett 2004, 4:1029-1034.
10. Sepúlveda B, Angelomé PC, Lechuga LM and Liz-Marzánb LM. LSPR-based nanobiosensors. Nano Today 2009, 4:244-251.
11. Jin R, Cao Y, Mirkin CA, Kelly KL, Schatz GC and Zheng JG. Photoinduced conversion of silver nanospheres to nanoprisms. Science 2001, 294:1901-1903.
12. Haes AJ, Zou S, Schatz GC and Van Duyne RP. Nanoscale optical biosensor: short range distance dependence of the localized surface plasmon resonance of noble metal nanoparticles. J Phys Chem B 2004, 108:6961-6968.
13. Yonzon CR, Jeoung E, Zou S, Schatz GC, Mrksich M and Van Duyne RP. A comparative analysis of localized and propagating surface plasmon resonance sensors: the binding of concanavalin A to a monosaccharide functionalized self-assembled monolayer. J Am Chem Soc 2004, 126:12669-12676.
14. Wu L, Huang MH, Zhao JL and Yang MS. Study of MMLV RT binding with DNA using surface plasmon resonance biosensor. Acta Biochem Biophys Sin 2005, 37:634-642.
15. Zhu SL, Li F, Du CL and Fu YQ. A localized surface plasmon resonance nanosensor based on rhombic Ag nanoparticle array. Sens Actuators B 2008, 134:193-198.
16. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B and Hallé JP, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001, 286:421-426.
17. Ruggenenti P and Remuzzi G. Time to abandon microalbuminuria? Kidney Int 2006, 70:1214-1222.
18. Gimeno-Orna JA, Molinero-Herguedas E, Sánchez-Vaño R, Lou-Arnal LM, Boned-Juliani B and Castro-Alonso FJ. Micro-albuminuria presents the same vascular risk as overt CVD in type 2 diabetes. Diabetes Res Clin Pract 2006, 74:103-109.
19. Solbu MD, Kronborg J, Jenssen TG, Njølstad I, Løchen ML, Mathiesen EB and Wilsgaard T, et al. Albuminuria metabolic syndrome and the risk of mortality and cardiovascular events. Atherosclerosis 2009, 204:503-508.
20. Magliano DJ, Polkinghorne KR, Barr EL, Su Q, Chadban SJ and Zimmet PZ, et al. HPLC-detected albuminuria predicts mortality. J Am Soc Nephrol 2007, 18:3171-3176.
21. Comper WD and Osicka TM. Detection of urinary albumin. Adv Chronic Kidney Dis 2005, 12:170-176.
22. Lakowicz JR, Malicka J, Matveeva E, Gryczynski I and Gryczynski Z. Plasmonic technology: novel approach to ultrasensitive immunoassays. Clin Chem 2005, 51:1914-1922.
23. Denham E, Mohn B, Tucker L, Lun A, Cleave P and Boswell DR. Evaluation of immunoturbidimetric specific protein methods using the Architect ci8200: comparison with immunonephelometry. Ann Clin Biochem 2007, 44:529-536.
24. Ma WY, Yao J, Yang H, Liu JY, Li F, Hilton JP and Lin Q. Effects of vertex truncation of polyhedral nanostructures on localized surface plasmon resonance. Opt Express 2009, 17:14967-14976.
25. Riboh JC, Haes AJ, McFarland AD, Yonzon CR and Van Duyne RP. A nanoscale optical biosensor: real-time immunoassay in physiological buffer enabled by improved nanoparticle adhesion. J Phys Chem B 2003, 107:1772-1780.
26. Endo T, Kerman K, Nagatani N, Hiepa HM, Kim DK, Yonezawa Y and Nakano K, et al. Multiple label-free detection of antigen-antibody reaction using localized surface plasmon resonance-based core-shell structured nanoparticle layer nanochip. Anal Chem 2006, 78:6465-6475.